LynxCare’s €20 Million Series A Funding Round

Linklaters advised LynxCare on the deal.

LynxCare announced a €20M round of Series A funding, which is the largest Series A round in Belgian digital health history. The funding round was led by the Swiss HealthTech Investor MTIP, joined by Elaia (FR), alongside early-stage investors Heran (BE), BtoV Partners (DE) and PMV (BE). This funding round will allow LynxCare to accelerate their international rollout and support of the team’s growth.

LynxCare is a big data specialist in healthcare, providing an AI-powered data platform that collects and analyses structured and unstructered clinical data for improved patient care and accelerated scientific research. Trough AI and language processing data-driven technology, LynxCare is leading an evolution towards value- and outcome- based healthcare to benefit patients, doctors, care providers and hospitals, while rigorously applying ethical standards and data protection legislation. 

Founded by Georges De Feu and Dries Hens in 2015, LynxCare today is a fast-growing Belgian scale-up company, employing around 35 people, unlocking clinical data across Europe and North-America. 

LynxCare was proudly assisted by Linklaters team Filip Lecoutre (Picture), Nils Vermeulen and Ludovic Meeus.


Involved fees earner: Filip Lecoutre – Linklaters; Ludovic Meeus – Linklaters; Nils Vermeulen – Linklaters;

Law Firms: Linklaters;

Clients: LynxCare;

Giulia Di Palma

Author: Giulia Di Palma